Merck and Siemens sell out of VisEn Medical in exit to New York-listed medical technology company PerkinElmer.
PerkinElmer, a New York-listed medical technology company, has acquired peer VisEn Medical from its corporate venturing backers for an undisclosed sum.
Although VisEn was formed in 2000, Germany-based industrial conglomerate Siemens made the first public strategic investment in the group in 2003. This was later followed by $16m in disclosed venture investments between August 2005 and April 2008 when Merck Capital Ventures, the $100m corporate venturing fund of US-based Merck & Co, co-led a $5m series B extension.
News provider…
